Fmoc-alpha-amino-DL-Gly(Boc)-OH

Fmoc-alpha-amino-DL-Gly(Boc)-OH is a protected glycine derivative used as an amino acid building block, combining an Fmoc-protected amino group with a Boc-protected side functionality on the glycine framework. The molecule contains a stereochemically defined glycine core presented as a DL mixture, while the orthogonal protecting groups (Fmoc for N-activation and Boc for acid-labile side protection) support controlled deprotection sequencing during peptide assembly. The carboxylic acid functionality enables standard peptide coupling chemistry, whereas the protected amine and carbamate groups modulate nucleophilicity and chemoselectivity under synthesis conditions. This protected amino acid intermediate is engineered for downstream conversion into peptide analogs and derivatized intermediates through orthogonal deprotection and functional group reactivity management.

1. Peptide Synthesis

Fmoc-alpha-amino-DL-Gly(Boc)-OH is applied in solid-phase peptide synthesis and solution-phase peptide construction as a glycine-based, orthogonally protected building block. The Fmoc group supports base-mediated removal to expose the N-terminus for iterative coupling, while the Boc-protected functionality can be retained or selectively removed depending on the desired sequence and side-chain chemistry. The free carboxylic acid participates in amide bond formation, enabling incorporation of glycine residues into peptide chains with controlled protection-state transitions. Downstream peptide products can include protected peptide fragments, peptide libraries, and sequence-defined intermediates used for biochemical research and synthetic methodology development.

2. Side-Chain Functionalization

Fmoc-alpha-amino-DL-Gly(Boc)-OH is suitable for amino acid derivatization workflows that require staged unveiling of reactive nitrogen functionality. The Boc-protected group provides an acid-labile handle that can be removed to generate an additional amine for subsequent coupling, carbamate formation, or formation of urea and amide linkages. The orthogonal Fmoc/Boc protection pattern supports selective transformations that preserve the peptide-compatible N-terminus while enabling targeted modification at the protected amino site. Resulting derivatives can serve as intermediates for peptidomimetic construction, scaffold diversification, and synthesis of functionalized glycine-containing molecules.

3. Chiral Building Block Development

Fmoc-alpha-amino-DL-Gly(Boc)-OH is used in chiral synthesis planning where glycine is incorporated as a stereochemically defined unit within a broader asymmetric sequence strategy, despite the DL designation reflecting a racemic amino acid mixture. The protected amino acid format allows the stereochemical outcome to be managed at the level of coupling partners and the surrounding chiral centers in the target molecule, while the orthogonal protecting groups maintain chemoselectivity during sequential steps. The Fmoc-protected amine and Boc-protected functionality help prevent side reactions that can complicate purification and stereochemical assessment in multi-step syntheses. The compound can therefore function as a controlled-protection chiral synthesis intermediate for generating stereochemically characterized peptide analogs and chiral molecular scaffolds.

4. Chemical Biology Probes

Fmoc-alpha-amino-DL-Gly(Boc)-OH is applied in chemical biology research to construct glycine-containing peptide probes and conjugatable linkers. The protected amine and carboxyl groups enable assembly of peptide segments that can later be deprotected to introduce reactive handles for labeling, affinity tag attachment, or bioconjugation chemistry. The orthogonal protection scheme supports preparation of defined conjugation-ready intermediates without premature exposure of nucleophilic sites that could interfere with probe synthesis. Downstream products can be used to generate labeled peptides, molecular recognition reagents, and assay-compatible probe scaffolds for studying biomolecular interactions.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-alpha-amino-DL-Gly(Boc)-OH is relevant to pharmaceutical manufacturing and fine chemical production workflows that rely on reproducible protected amino acid intermediates for peptide-derived substances. The Fmoc/Boc orthogonal protection strategy aligns with industrially scalable protection and deprotection sequences, enabling controlled generation of coupling-ready amines and minimization of side reactions during intermediate isolation. The carboxylic acid functionality supports standard peptide coupling chemistries used to build peptide-based intermediates and defined oligomeric structures. The resulting protected peptide fragments and derivatized intermediates can feed into downstream manufacturing steps for peptide materials, process development studies, and analytical method support.

6. Analytical Reference Standards

Fmoc-alpha-amino-DL-Gly(Boc)-OH can be employed in analytical research as a structurally characterized protected amino acid reference for method development and impurity profiling in peptide synthesis workflows. The presence of two orthogonal protecting groups (Fmoc and Boc) provides distinct chromatographic and spectroscopic signatures that help track deprotection completeness, monitor protecting-group stability, and identify related synthesis impurities. The glycine backbone and defined protection-state facilitate comparison across batches and support verification of intermediate identity during process chemistry optimization. Analytical use can extend to calibration of LC-MS/MS transitions and confirmation of peptide coupling intermediates in peptide building block preparation and peptide assembly studies.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I